Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K<sub>2(20)</sub>, on All-Trans Retinoic Acid-Resistant HL60 Cell Line
The first-choice drug for acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA), frequently causes drug-resistance and some adverse effects. Thus, an effective and safe agent for ATRA-resistant APL is needed. Menaquinone-4 (MK-4, vitamin K<sub>2(20)</sub>), used for osteopor...
Main Authors: | Hirofumi Yamakawa, Shuichi Setoguchi, Shotaro Goto, Daisuke Watase, Kazuki Terada, Nami Nagata-Akaho, Erina Toki, Mitsuhisa Koga, Kazuhisa Matsunaga, Yoshiharu Karube, Jiro Takata |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/758 |
Similar Items
-
Prodrugs for Skin Delivery of Menahydroquinone-4, an Active Form of Vitamin K<sub>2(20)</sub>, Could Overcome the Photoinstability and Phototoxicity of Vitamin K<sub>2(20)</sub>
by: Shotaro Goto, et al.
Published: (2019-05-01) -
Antitumor Effects and Delivery Profiles of Menahydroquinone-4 Prodrugs with Ionic or Nonionic Promoiety to Hepatocellular Carcinoma Cells
by: Shuichi Setoguchi, et al.
Published: (2018-07-01) -
Novel Cationic Prodrug of Ubiquinol-10 Enhances Intestinal Absorption via Efficient Formation of Nanosized Mixed-Micelles with Bile Acid Anions
by: Shuichi Setoguchi, et al.
Published: (2020-01-01) -
Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
by: Munechika Enjoji, et al.
Published: (2015-07-01) -
Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study
by: Kazuki Terada, et al.
Published: (2020-09-01)